Tolvaptan Lowers Kidney Stone Risk in ADPKD
Tolvaptan improves the urinary lithogenic risk profile of patients with autosomal dominant polycystic kidney disease, according to researchers.
All articles by Natasha Persaud
New PCR to ACR Conversion Equation May Enhance CKD Diagnosis, Prognosis
Practitioners who measure only urinary protein-to-creatinine ratio may be able to use a new albumin-to-creatinine ratio estimating equation to diagnose and manage kidney disease.
COVID-19 Outcomes in Kidney Failure Cases Described
In separate COVID-19 studies, investigators found that only some infected kidney transplant outpatients required hospitalization and patients on maintenance hemodialysis often have an atypical presentation of symptoms.
Expanding Options for Kidney Failure Patients
Gradual transition to dialysis and palliative dialysis should be alternatives offered to patients with advanced chronic kidney disease, according to an editorial.
Salvage RARP After HIFU Partial Ablation Safe, Feasible
In a small study, 1 in 3 prostate cancer patients who underwent salvage robotic-assisted radical prostatectomy following partial ablation with high-intensity focused ultrasound required adjuvant radiation or androgen deprivation therapy within 12 months.
Urinary Symptom Improvement Similar With TURP, ThuVARP
Thulium laser transurethral vaporesection of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia resulted in comparable improvements in International Prostate Symptom Score over 12 months.
GnRH Antagonist vs Agonist for Metastatic Prostate Cancer Tied With Lower Mortality
Use of a gonadotropin-releasing hormone antagonist is associated with lower risks for death than GnRH agonists, a systematic review and meta-analysis found.
Limited ESA Use in COVID-19 Patients Recommended
Infection with the virus that causes COVID-19, coupled with use of erythropoiesis-stimulating agents may result in additive prothrombotic effects, according to the authors.
Adverse Drug Reactions Common in CKD
Nearly a third of serious adverse drug reactions in patients with chronic kidney disease may be preventable, according to investigators.
Potassium Binder May Increase Sodium Bicarbonate in CKD
In 3 trials of sodium zirconium cyclosilicate, serum bicarbonate increased regardless of CKD stage.
-
Loading...
-
Loading...
Next post in Hyperkalemia
